Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 1
1951 1
1952 2
1956 1
1959 3
1960 1
1961 3
1962 6
1963 7
1964 2
1965 3
1967 5
1968 4
1969 6
1970 1
1971 4
1972 5
1973 7
1974 2
1975 8
1976 13
1977 8
1978 13
1979 19
1980 18
1981 15
1982 23
1983 20
1984 32
1985 32
1986 27
1987 41
1988 32
1989 55
1990 67
1991 82
1992 82
1993 75
1994 82
1995 82
1996 72
1997 109
1998 111
1999 139
2000 130
2001 132
2002 104
2003 102
2004 156
2005 129
2006 141
2007 140
2008 165
2009 153
2010 136
2011 147
2012 145
2013 150
2014 174
2015 189
2016 173
2017 173
2018 156
2019 124
2020 91
Text availability
Article attribute
Article type
Publication date

Search Results

4,023 results
Results by year
Filters applied: . Clear all
Page 1
Identification of a missense variant in the WFS1 gene that causes a mild form of Wolfram syndrome and is associated with risk for type 2 diabetes in Ashkenazi Jewish individuals.
Bansal V, Boehm BO, Darvasi A. Bansal V, et al. Diabetologia. 2018 Oct;61(10):2180-2188. doi: 10.1007/s00125-018-4690-3. Epub 2018 Jul 16. Diabetologia. 2018. PMID: 30014265
RESULTS: The missense variant demonstrated an allele frequency of 1.4% in individuals of Ashkenazi Jewish ancestry, 60-fold higher than in other populations. ...This variant should be considered for genetic testing in individuals of Ashkenazi ancestry diagnosed with …
RESULTS: The missense variant demonstrated an allele frequency of 1.4% in individuals of Ashkenazi Jewish ancestry, 60-fold higher th …
A founder deletion in the TRPM1 gene associated with congenital stationary night blindness and myopia is highly prevalent in Ashkenazi Jews.
Hirsch Y, Zeevi DA, Lam BL, Scher SY, Bringer R, Cherki B, Cohen CC, Muallem H, Chiang JP, Pantrangi M, Ekstein J, Johansson MM. Hirsch Y, et al. Hum Genome Var. 2019 Sep 12;6:45. doi: 10.1038/s41439-019-0076-4. eCollection 2019. Hum Genome Var. 2019. PMID: 31645983 Free PMC article.
Heterozygous TRPM1 deletions were found in 2.75% (1/36) of Ashkenazi subjects and in 1.22% (1/82) individuals of mixed Ashkenazi/Sephardic origin. ...This deletion is a founder Ashkenazi Jewish deletion....
Heterozygous TRPM1 deletions were found in 2.75% (1/36) of Ashkenazi subjects and in 1.22% (1/82) individuals of mixed Ashkenazi
Immunoadhesins.
Ashkenazi A, Capon DJ, Ward RH. Ashkenazi A, et al. Int Rev Immunol. 1993;10(2-3):219-27. doi: 10.3109/08830189309061697. Int Rev Immunol. 1993. PMID: 7689624 Review. No abstract available.
Traveler's Diarrhea: The Other Side of the Coin.
Ashkenazi S. Ashkenazi S. Isr Med Assoc J. 2019 Aug;21(8):552-554. Isr Med Assoc J. 2019. PMID: 31474019 Free article. No abstract available.
Founder BRCA1 and BRCA2 mutations in Ashkenazi Jews in Israel: frequency and differential penetrance in ovarian cancer and in breast-ovarian cancer families.
Levy-Lahad E, Catane R, Eisenberg S, Kaufman B, Hornreich G, Lishinsky E, Shohat M, Weber BL, Beller U, Lahad A, Halle D. Levy-Lahad E, et al. Am J Hum Genet. 1997 May;60(5):1059-67. Am J Hum Genet. 1997. PMID: 9150153 Free PMC article.
In Ashkenazi Jews, there is a high population frequency (approximately 2%) of three founder mutations: BRCA1 185delAG, BRCA1 5382insC, and BRCA2 6174delT. ...There was a high frequency (10/22; [45%]) of germ-line mutations in Ashkenazi women with ovarian cancer, eve …
In Ashkenazi Jews, there is a high population frequency (approximately 2%) of three founder mutations: BRCA1 185delAG, BRCA1 5382insC …
Cost-effectiveness of population based BRCA testing with varying Ashkenazi Jewish ancestry.
Manchanda R, Patel S, Antoniou AC, Levy-Lahad E, Turnbull C, Evans DG, Hopper JL, Macinnis RJ, Menon U, Jacobs I, Legood R. Manchanda R, et al. Am J Obstet Gynecol. 2017 Nov;217(5):578.e1-578.e12. doi: 10.1016/j.ajog.2017.06.038. Epub 2017 Jul 6. Am J Obstet Gynecol. 2017. PMID: 28690137 Free article.
BACKGROUND: Population-based BRCA1/BRCA2 testing has been found to be cost-effective compared with family history-based testing in Ashkenazi-Jewish women were >30 years old with 4 Ashkenazi-Jewish grandparents. ...These results support population testing in As
BACKGROUND: Population-based BRCA1/BRCA2 testing has been found to be cost-effective compared with family history-based testing in Ashken
Multigene panels in Ashkenazi Jewish patients yield high rates of actionable mutations in multiple non-BRCA cancer-associated genes.
Frey MK, Sandler G, Sobolev R, Kim SH, Chambers R, Bassett RY, Martineau J, Sapra KJ, Boyd L, Curtin JP, Pothuri B, Blank SV. Frey MK, et al. Gynecol Oncol. 2017 Jul;146(1):123-128. doi: 10.1016/j.ygyno.2017.04.009. Epub 2017 May 8. Gynecol Oncol. 2017. PMID: 28495237
OBJECTIVE: To evaluate the results of multigene panel testing among Ashkenazi Jewish compared with non-Ashkenazi Jewish patients. ...Twenty mutations were identified by multigene panels among Ashkenazi Jewish patients, 18 of which were in genes other than BRC …
OBJECTIVE: To evaluate the results of multigene panel testing among Ashkenazi Jewish compared with non-Ashkenazi Jewish patien …
Non-Ashkenazi Jewish Origin is Associated with Early Onset Alzheimer's Disease.
Keret O, Shochat T, Steiner I, Glik A. Keret O, et al. J Alzheimers Dis. 2018;65(3):877-884. doi: 10.3233/JAD-180331. J Alzheimers Dis. 2018. PMID: 30103328
The association of non-Ashkenazi Jewish heritage and country of origin with EOAD was calculated using a logistic multivariate regression model. ...There were no significant differences in parameters between non-Ashkenazi and Ashkenazi Jews. Only 4.6% of EOAD …
The association of non-Ashkenazi Jewish heritage and country of origin with EOAD was calculated using a logistic multivariate regress …
Natural history of Ashkenazi intelligence.
Cochran G, Hardy J, Harpending H. Cochran G, et al. J Biosoc Sci. 2006 Sep;38(5):659-93. doi: 10.1017/S0021932005027069. J Biosoc Sci. 2006. PMID: 16867211 Review.
In particular we propose that the well-known clusters of Ashkenazi genetic diseases, the sphingolipid cluster and the DNA repair cluster in particular, increase intelligence in heterozygotes. Other Ashkenazi disorders are known to increase intelligence. Although the …
In particular we propose that the well-known clusters of Ashkenazi genetic diseases, the sphingolipid cluster and the DNA repair clus …
The effect of CAG repeats length on differences in hirsutism among healthy Israeli women of different ethnicities.
Weintrob N, Eyal O, Slakman M, Segev Becker A, Ish-Shalom M, Israeli G, Kalter-Leibovici O, Ben-Shachar S. Weintrob N, et al. PLoS One. 2018 Mar 27;13(3):e0195046. doi: 10.1371/journal.pone.0195046. eCollection 2018. PLoS One. 2018. PMID: 29584789 Free PMC article.
RESULTS: One-hundred and eight women were recruited (49 Ashkenazi and 59 non-Ashkenazi). The Ashkenazi women had a significantly lower degree of hirsutism (P<0.01), lower mean BMI (P = 0.003), total testosterone levels (P = 0.017), and longer weighted bi-a …
RESULTS: One-hundred and eight women were recruited (49 Ashkenazi and 59 non-Ashkenazi). The Ashkenazi women had a sign …
4,023 results
Jump to page
Feedback